share_log

科华生物(002022.SZ):肌酸激酶同工酶测定试剂盒获得医疗器械注册证

Shanghai Kehua Bio-Engineering (002022.SZ): Creatine Kinase Isoenzyme Assay Kit obtained the registration certificate for medical instruments.

Gelonghui Finance ·  Nov 20, 2024 15:48

Shanghai kehua bio-engineering (002022.SZ) stated on the investor interaction platform today that the company recently obtained a medical device registration certificate (in vitro diagnostic reagent) issued by the Shanghai Municipal Food and Drug Administration. The product is named Creatine Kinase Isoenzyme Assay Kit (Latex Immunoassay), this assay kit is supplied to medical institutions for the quantitative determination of creatine kinase isoenzyme in human serum or plasma samples, clinically used for the auxiliary diagnosis of diseases such as myocardial infarction and myopathy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment